ZyVersa Therapeutics’ CEO, Stephen C. Glover to Attend the 38th Annual J.P. Morgan Healthcare Conference 2020
WESTON, Fla., Jan. 6, 2020 /PRNewswire/ — ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of renal and inflammatory diseases, is pleased to announce that Stephen C. Glover, ZyVersa’s Co-Founder,…
Comments Off on ZyVersa Therapeutics’ CEO, Stephen C. Glover to Attend the 38th Annual J.P. Morgan Healthcare Conference 2020